Targeting gut bacteria may improve levodopa uptakeMarch 27, 2020Parkinson's DiseaseMovement Disorders
Expert says progress in gut-brain research requires an open mindMarch 13, 2020Parkinson's DiseaseAlzheimer's & CognitionMultiple SclerosisEpilepsy & SeizuresHeadache & MigraineMovement DisordersNeuromuscular Disorders
As costs for neurologic drugs rise, adherence to therapy dropsFebruary 21, 2020Mixed TopicsAlzheimer's & CognitionMovement DisordersParkinson's DiseaseMultiple SclerosisEpilepsy & SeizuresNeuromuscular Disorders
Palliative care improves QoL for patients with Parkinson’s disease and related disordersFebruary 10, 2020Parkinson's DiseaseMovement Disorders
APOE genotype directly regulates alpha-synuclein accumulationFebruary 10, 2020Parkinson's DiseaseAlzheimer's & CognitionMovement Disorders
Pimavanserin reduced dementia-related psychotic symptoms without affecting cognitionDecember 13, 2019Alzheimer's & CognitionParkinson's DiseaseMovement Disorders
Parkinson’s patients can lose swimming ability after deep brain stimulationDecember 3, 2019Parkinson's DiseaseMovement Disorders
Antibiotic use may increase the risk of Parkinson’s diseaseDecember 3, 2019Parkinson's DiseaseMovement DisordersMixed Topics
FDA approves onabotulinumtoxinA for pediatric lower limb spasticityOctober 24, 2019Movement DisordersPediatrics
Increased Parkinson’s disease risk seen with bipolar disorderOctober 14, 2019Parkinson's DiseaseMovement Disorders
FDA expands Dysport’s upper-limb spasticity indication to childrenSeptember 27, 2019Movement DisordersPediatrics
FDA approves istradefylline for Parkinson’s diseaseAugust 28, 2019Parkinson's DiseaseMovement Disorders
Progression in Huntington’s linked to CAG repeat numberAugust 16, 2019Huntington's DiseaseMovement Disorders
